Systematic review: Management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis

Systematic review: Management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis

Veure altres versions (1)

Background Primary sclerosing cholangitis (PSC) remains a challenging disease to manage. The main goals are prevention of disease progression and reduction of the increased cancer risk. Aims To review the management strategies for PSC and its variant forms based on published studies. Methods Publica...

Descripció completa

Dades bibliogràfiques
Autors principals:	Culver, E, Chapman, R
Format:	Journal article
Idioma:	English
Publicat:	Wiley 2011

Ítems similars

Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis.
per: Culver, E, et al.
Publicat: (2011)

Autoimmune pancreatitis/IgG4-associated cholangitis and primary sclerosing cholangitis--overlapping or separate diseases?
per: Webster, G, et al.
Publicat: (2009)

IgG4-related sclerosing cholangitis
per: Culver, E, et al.
Publicat: (2017)

IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis
per: Atsushi Tanaka
Publicat: (2019-05-01)

IgG4-Seronegative Autoimmune Pancreatitis and Sclerosing Cholangitis
per: Allon Kahn, et al.
Publicat: (2015-01-01)

IgG4-related sclerosing cholangitis
per: Terumi Kamisawa, et al.
Publicat: (2011-10-01)

Autoimmune cholangitis associated to IgG4 related sclerosing disease
per: Bernardo Frider, et al.
Publicat: (2011-01-01)

Overlap Syndrome with Autoimmune Hepatitis and Primary Sclerosing Cholangitis
per: Jeremy S. Nayagam, et al.
Publicat: (2019-05-01)

Epigenetic age acceleration and methylation differences in IgG4-related cholangitis and primary sclerosing cholangitis
per: Noble, A, et al.
Publicat: (2025)

Epigenetic age acceleration and methylation differences in IgG4-related cholangitis and primary sclerosing cholangitis
per: Alexandra Noble, et al.
Publicat: (2025-01-01)

A novel serum metabolomic panel distinguishes IgG4-related sclerosing cholangitis from primary sclerosing cholangitis
per: Radford-Smith, DE, et al.
Publicat: (2022)

Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.
per: Saich, R, et al.
Publicat: (2008)

IgG4-Related Sclerosing Cholangitis Mimicking Cholangiocarcinoma
per: Pham Minh Thong, et al.
Publicat: (2021-02-01)

Classification and Diagnostic Criteria for IgG4-Related Sclerosing Cholangitis
per: Itaru Naitoh, et al.
Publicat: (2022-01-01)

IgG4-related sclerosing cholangitis: A case report
per: Haoran Hu, et al.
Publicat: (2023-07-01)

Sclerosing cholangitis associated with IgG4 disease. Case Report
per: A Torres Castro, et al.
Publicat: (2022-12-01)

Difficulties in Diagnosing Isolated IgG4-associated Sclerosing Cholangitis
per: Gábor Zsóri, et al.
Publicat: (2019-01-01)

A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome
per: Benedetta Terziroli Beretta-Piccoli, et al.
Publicat: (2020-01-01)

Isolated variant of IgG4-sclerosing cholangitis masquerading as hilar cholangiocarcinoma — an enigmatic entity
per: Soundarya Ravi, et al.
Publicat: (2023-05-01)

Autoimmune hepatitis and primary sclerosing cholangitis overlap syndrome in inflammatory bowel diseases
per: Joanna Saganek, et al.
Publicat: (2023-09-01)

Coexisting Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Overlapping Challenges in Diagnosis and Treatment
per: Hannah W. Fiske, et al.
Publicat: (2024-03-01)

Management of biliary stricture in patients with IgG4-related sclerosing cholangitis.
per: Masaki Miyazawa, et al.
Publicat: (2020-01-01)

Sclerosing Cholangitis Related to IgG4: Not Always a Curable Entity
per: Fernando Martínez-Valle, et al.
Publicat: (2019-01-01)

Colangitis autoinmune asociada a IgG4 Autoimmune cholangitis IgG4
per: J. M. Ramia Ángel, et al.
Publicat: (2011-02-01)

Elevated serum and tissue levels of IgG4 in Primary Sclerosing Cholangitis are associated with a worse clinical outcome
per: Culver, E, et al.
Publicat: (2012)

Sclerosing cholangitis
per: Martins, E, et al.
Publicat: (1998)

Sclerosing cholangitis
per: Martins, E, et al.
Publicat: (1997)

Sclerosing cholangitis.
per: Björnsson, E, et al.
Publicat: (2003)

Sclerosing cholangitis.
per: Martins, E, et al.
Publicat: (2001)

Sclerosing cholangitis.
per: Martins, E, et al.
Publicat: (1999)

Sclerosing cholangitis.
per: Martins, E, et al.
Publicat: (2000)

SCLEROSING CHOLANGITIS
per: Martins, E, et al.
Publicat: (1995)

Sclerosing cholangitis
per: Martins, E, et al.
Publicat: (1996)

Sclerosing cholangitis.
per: Maggs, JR, et al.
Publicat: (2007)

ANTINEUTROPHIL CYTOPLASMIC ANTIBODY TITER BUT NOT IGG SUBCLASS DISTINGUISHES BETWEEN PRIMARY SCLEROSING CHOLANGITIS AND AUTOIMMUNE HEPATITIS
per: Bans, D, et al.
Publicat: (1995)

Sclerosing cholangitis.
per: MacFaul, G, et al.
Publicat: (2005)

Sclerosing cholangitis.
per: MacFaul, G, et al.
Publicat: (2004)

Sclerosing cholangitis.
per: MacFaul, G, et al.
Publicat: (2006)

IgG4-Related Sclerosing Cholangitis: Rarely Diagnosed, but not a Rare Disease
per: Sylvia Drazilova, et al.
Publicat: (2021-01-01)

Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort.
per: Huggett, M, et al.
Publicat: (2014)